Amidst concerns that doctors often over-prescribe, the Chinese government decided last year to stop hospitals working as distribution channels for pharmaceuticals by banning drug mark-ups. But Manaen Ma, a self-employed consultant on China’s healthcare industry, says that a ban cannot substitute better funding for indebted hospitals - and that the practice is still going on.